Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria

Clinical trial NCT01713725 · COMPLETED

Trial details

NCT number: NCT01713725
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Urticaria

Start date: 2012-03-01
Primary completion: 2016-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.